HomeBBIO • NASDAQ
add
BridgeBio Pharma Inc
Previous close
$67.61
Day range
$65.46 - $68.47
Year range
$28.33 - $84.94
Market cap
12.88B USD
Avg Volume
3.45M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 154.18M | 2,521.18% |
Operating expense | 274.50M | 21.93% |
Net income | -192.86M | 27.24% |
Net profit margin | -125.09 | 97.22% |
Earnings per share | -0.94 | 31.68% |
EBITDA | -127.00M | 42.27% |
Effective tax rate | 0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 587.48M | -13.75% |
Total assets | 936.02M | 1.82% |
Total liabilities | 3.01B | 26.74% |
Total equity | -2.08B | — |
Shares outstanding | 193.55M | — |
Price to book | -6.27 | — |
Return on assets | -33.20% | — |
Return on capital | 231.74% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -192.86M | 27.24% |
Cash from operations | -56.42M | 71.11% |
Cash from investing | -14.35M | -343.44% |
Cash from financing | -2.18M | -100.46% |
Net change in cash | -72.96M | -126.49% |
Free cash flow | -27.52M | -187.26% |
About
CEO
Founded
2015
Headquarters
Website
Employees
834
